CROP PHARM LTD

Active London

Wholesale of pharmaceutical goods

0 employees website.com
Wholesale of pharmaceutical goods
C

CROP PHARM LTD

Wholesale of pharmaceutical goods

Founded 26 Jul 2023 Active London, England 0 employees website.com
Wholesale of pharmaceutical goods
Accounts Submitted 30 Apr 2026 Next due 30 Apr 2026 27 days overdue
Confirmation Submitted 12 Aug 2025 Next due 8 Aug 2026 2 months remaining
Net assets £-38K
Total assets £15K
Total Liabilities £53K
Charges None No charges registered

Contact & Details

Contact

Registered Address

7 Bell Yard London WC2A 2JR England

Full company profile for CROP PHARM LTD (15029917), an active company based in London, England. Incorporated 26 Jul 2023. Wholesale of pharmaceutical goods. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Aug → 31 Jul 2024
Type total-exemption-full
Next accounts 31 Jul 2025
Due by 30 Apr 2026 1 month overdue

Net Assets, Total Assets & Total Liabilities (2024–2024)

Cash in Bank

£15.29k

Net Assets

-£37.61k

Total Liabilities

£52.90k

Turnover

N/A

Employees

N/A

Debt Ratio

346%

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Jul Year End
P&L
Revenue
£142.3M
Gross Profit
£48.2M
Operating Profit
£22.4M
Net Profit
£18.1M
EBITDA
£31.5M
Assets
Cash
£24.7M
Total Assets
£89.4M
Liabilities
Total Liabilities
£45.2M
Key Metrics
Employees
1,247
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

3 active
Status
Jonathan David NadlerDirectorBritishUnited Kingdom4426 Jul 2023Active
Musiol, Markus LaurentiusDirectorGermanGermany2830 Jan 2026Active
Toby Waldock ShillitoDirectorBritishUnited Kingdom5526 Jul 2023Active

Shareholders

Shareholders (2)

Jonathan David Nadler
50.0%
Toby Waldock Shillito
50.0%

Persons with Significant Control

Persons with Significant Control (3)

3 Active

Toby Waldock Shillito

British

Active
Notified 26 Jul 2023
Residence United Kingdom
DOB June 1970
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent,right To Appoint And Remove Directors

Jonathan David Nadler

British

Active
Notified 26 Jul 2023
Residence United Kingdom
DOB May 1982
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent,right To Appoint And Remove Directors

Enua Pharma Gmbh

Unknown

Active
Notified 30 Jan 2026
Nature of Control
  • Ownership Of Shares 75 To 100 Percent
  • Voting Rights 75 To 100 Percent
  • Right To Appoint And Remove Directors

Group Structure

Group Structure

CROP PHARM LTD Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
30 Apr 2026AccountsAnnual accounts made up to 31 Jul 2025
23 Apr 2026Persons With Significant ControlEnua Pharma Gmbh notified as a person with significant control
21 Apr 2026Persons With Significant ControlWithdrawal Of A Person With Significant Control Statement
6 Feb 2026Persons With Significant ControlCessation of Toby Waldock Shillito as a person with significant control on 30 Jan 2026
6 Feb 2026OfficersTermination of Toby Waldock Shillito as director on 30 Jan 2026
30 Apr 2026 Accounts

Annual accounts made up to 31 Jul 2025

23 Apr 2026 Persons With Significant Control

Enua Pharma Gmbh notified as a person with significant control

21 Apr 2026 Persons With Significant Control

Withdrawal Of A Person With Significant Control Statement

6 Feb 2026 Persons With Significant Control

Cessation of Toby Waldock Shillito as a person with significant control on 30 Jan 2026

6 Feb 2026 Officers

Termination of Toby Waldock Shillito as director on 30 Jan 2026

Recent Activity

Latest Activity

Annual accounts made up to 31 Jul 2025

3 weeks ago on 30 Apr 2026

Enua Pharma Gmbh notified as a person with significant control

1 months ago on 23 Apr 2026

Withdrawal Of A Person With Significant Control Statement

1 months ago on 21 Apr 2026

Cessation of Toby Waldock Shillito as a person with significant control on 30 Jan 2026

3 months ago on 6 Feb 2026

Termination of Toby Waldock Shillito as director on 30 Jan 2026

3 months ago on 6 Feb 2026